Top Stories

Consortium to buy S.Africa hospitals firm Mediclinic for $4.49 billion

Published by Wanda Rich

Posted on August 4, 2022

2 min read

· Last updated: February 5, 2026

Add as preferred source on Google
Mediclinic logo displayed prominently, representing the hospital chain involved in the $4.49 billion acquisition - Global Banking & Finance Review
The image features the Mediclinic logo, a key player in the healthcare sector. This logo is central to the recent $4.49 billion acquisition by Remgro Ltd and MSC, highlighting significant developments in South Africa's healthcare industry.
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -South Africa’s Remgro Ltd said on Thursday it will buy hospital chain operator Mediclinic International in a consortium with Switzerland’s MSC Mediterranean Shipping for 3.7 billion pounds ($4.49 billion). The offer, which was the consortium’s fourth after the earlier ones were rejected by Mediclinic’s board, values the company at 6.1 billion pounds ($7.41 billion), […]

(Reuters) -South Africa’s Remgro Ltd said on Thursday it will buy hospital chain operator Mediclinic International in a consortium with Switzerland’s MSC Mediterranean Shipping for 3.7 billion pounds ($4.49 billion).

The offer, which was the consortium’s fourth after the earlier ones were rejected by Mediclinic’s board, values the company at 6.1 billion pounds ($7.41 billion), Remgro and Mediclinic said in a joint statement.

Mediclinic is South Africa’s third biggest operator of hospitals and billionaire tycoon Johann Rupert’s Remgro already owns up to 45% of the company.

Remgro, an investment company with operations spread across financial services, consumer products, infrastructure and healthcare, had been under pressure from investors and shareholders to unlock value and simplify the group structure.

Its plan to buy out Mediclinic is part of those efforts.

Mediclinic had dragged on Remgro’s earnings as the hospital chain was hit by the COVID-19 pandemic and revenue from surgeries and other procedures dropped.

However, it has largely returned to normal operations and analysts had said the time was ripe for Remgro to unlock value in the company that could benefit shareholders.

Shareholders of Mediclinic will receive 504 pence in cash for each share of Mediclinic, a premium of 23% from the day before the final offer was made in early June, the companies said.

Mediclinic also has operations in Switzerland and the Middle East and is listed in the UK and South Africa.

If the offer is approved by shareholders, Mediclinic will be delisted and held as a private company by the consortium, they said.

($1 = 0.8235 pounds)

(Reporting by Promit Mukherjee in Johannesburg and Sinchita Mitra in Bengaluru; editing by Rashmi Aich and Jason Neely)

Frequently Asked Questions

What is a consortium?
A consortium is a group of individuals or organizations that come together to collaborate on a specific project or investment, sharing resources and expertise to achieve common goals.
What is an investment company?
An investment company is a financial institution that pools money from investors to purchase securities, such as stocks and bonds, aiming to generate returns for its shareholders.
What is a share premium?
A share premium is the amount received by a company over and above the nominal value of its shares when they are issued to investors.
What is a delisting?
Delisting refers to the removal of a company's stock from a stock exchange, which can occur voluntarily or involuntarily, often following a merger or acquisition.

Tags

Related Articles

More from Top Stories

Explore more articles in the Top Stories category